Bosutinib‐Associated Cardiac Tamponade: Late‐Onset Treatment‐Emergent Adverse Event—A Case Report
Mehmet Ası Oktan, Hüseyin Dursun, Yelda Deligöz Bildacı, Berfu Korucu, Cihan Heybeli, Caner Çavdar, Serpil Müge Değer · 2026
Read Bosutinib‐Associated Cardiac Tamponade: Late‐Onset Treatment‐Emergent Adverse Event—A Case Report by Mehmet Ası Oktan, Hüseyin Dursun, Yelda Deligöz Bildacı, Berfu Korucu, Cihan Heybeli, Caner Çavdar, Serpil Müge Değer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13136675.txt.
Description
Mehmet Ası Oktan and co-authors published this case report in 2026. A man of sixty-three was on bosutinib, a targeted drug for blood cancer. Such drugs can make the body hold fluid. His case grew grave: fluid pressed on the heart, a state called tamponade, joined by heart failure, kidney injury, and swelling across the body. The team present it as a late-onset harm of the drug, a warning that fluid build-up on this therapy can turn into an emergency that squeezes the heart.
Catalog record
| CREATOR | Mehmet Ası Oktan, Hüseyin Dursun, Yelda Deligöz Bildacı, Berfu Korucu, Cihan Heybeli, Caner Çavdar, Serpil Müge Değer |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |